DK29287A - 7-(azabicycloalkyl)-quinoloncarboxylsyre- og -naphthyridonboxylsyrederivater, deres fremstilling og anvendelse - Google Patents

7-(azabicycloalkyl)-quinoloncarboxylsyre- og -naphthyridonboxylsyrederivater, deres fremstilling og anvendelse

Info

Publication number
DK29287A
DK29287A DK029287A DK29287A DK29287A DK 29287 A DK29287 A DK 29287A DK 029287 A DK029287 A DK 029287A DK 29287 A DK29287 A DK 29287A DK 29287 A DK29287 A DK 29287A
Authority
DK
Denmark
Prior art keywords
acid
naphthyridonboxylic
azabicycloalkyl
preparation
quinoloncarboxylic
Prior art date
Application number
DK029287A
Other languages
Danish (da)
English (en)
Other versions
DK29287D0 (da
Inventor
Uwe Petersen
Klaus Grohe
Thomas Schenke
Hermann Hagemann
Hans-Joachim Zeiler
Karl Georg Metzger
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK29287D0 publication Critical patent/DK29287D0/da
Publication of DK29287A publication Critical patent/DK29287A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK029287A 1986-01-21 1987-01-20 7-(azabicycloalkyl)-quinoloncarboxylsyre- og -naphthyridonboxylsyrederivater, deres fremstilling og anvendelse DK29287A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863601567 DE3601567A1 (de) 1986-01-21 1986-01-21 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate

Publications (2)

Publication Number Publication Date
DK29287D0 DK29287D0 (da) 1987-01-20
DK29287A true DK29287A (da) 1987-07-22

Family

ID=6292237

Family Applications (1)

Application Number Title Priority Date Filing Date
DK029287A DK29287A (da) 1986-01-21 1987-01-20 7-(azabicycloalkyl)-quinoloncarboxylsyre- og -naphthyridonboxylsyrederivater, deres fremstilling og anvendelse

Country Status (16)

Country Link
EP (1) EP0230274A3 (xx)
JP (1) JPS62169789A (xx)
KR (1) KR870007176A (xx)
CN (1) CN87100354A (xx)
AU (1) AU6746387A (xx)
DD (1) DD265401A5 (xx)
DE (1) DE3601567A1 (xx)
DK (1) DK29287A (xx)
FI (1) FI870200A (xx)
HU (1) HUT45531A (xx)
IL (1) IL81291A0 (xx)
NO (1) NO870126L (xx)
PL (1) PL263735A1 (xx)
PT (1) PT84135A (xx)
SU (1) SU1538897A3 (xx)
ZA (1) ZA87380B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0251308B1 (de) * 1986-07-04 1990-11-22 Chemie Linz Gesellschaft m.b.H. 4-Chinolon-3-carbonsäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
ZA877471B (en) * 1986-10-08 1988-04-05 Bristol-Myers Company 1-tertiary-alkyl-substituted naphthyridine-and quinoline-carboxylic acid antibacterial agents
WO1989000158A1 (en) * 1987-07-02 1989-01-12 Pfizer Inc. Bridged-diazabicycloalkyl quinolone carboxylic acids and esters
US4923879A (en) * 1987-07-31 1990-05-08 Warner-Lambert Company 1,8-Naphthyridines and their use as antibacterial agents
US4968799A (en) * 1987-07-31 1990-11-06 Warner-Lambert Company Antibacterial agents
US4992546A (en) * 1987-07-31 1991-02-12 Warner-Lambert Company Process for preparing 6,8-diazabicyclo[3.2.2]nonane derivatives
JPH0228178A (ja) * 1988-04-23 1990-01-30 Toyama Chem Co Ltd 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法
KR910003630B1 (ko) * 1988-06-17 1991-06-07 한국과학기술원 벤조일 아세틱 에스테르 유도체 및 그 제조방법
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
WO1991004972A1 (en) * 1989-10-06 1991-04-18 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
US5385913A (en) * 1989-10-06 1995-01-31 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
FR2656611B1 (fr) * 1990-01-04 1992-05-07 Hoechst France Nouvelles quinolones, leurs sels, utiles comme agents antimicrobiens, procede de preparation et leur application a titre de medicaments et compositions les renfermant.
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
US6184380B1 (en) 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates
US7019142B2 (en) 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
SE0003795D0 (sv) 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3281423A (en) * 1964-02-03 1966-10-25 Merck & Co Inc 1, 3-ethanopiperazines and process
EP0090424B1 (en) * 1982-03-31 1986-05-28 Sterling Drug Inc. New quinolone compounds and preparation thereof
NZ208470A (en) * 1983-07-18 1988-06-30 Abbott Lab 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such
IL74244A (en) * 1984-02-17 1988-06-30 Warner Lambert Co Quinoline derivatives,their preparation and pharmaceutical compositions containing them
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
IN166416B (xx) * 1985-09-18 1990-05-05 Pfizer

Also Published As

Publication number Publication date
IL81291A0 (en) 1987-08-31
CN87100354A (zh) 1987-09-02
PL263735A1 (en) 1988-07-21
ZA87380B (en) 1987-09-30
FI870200A0 (fi) 1987-01-19
EP0230274A3 (de) 1988-03-09
EP0230274A2 (de) 1987-07-29
NO870126L (no) 1987-07-22
PT84135A (en) 1987-02-01
SU1538897A3 (ru) 1990-01-23
FI870200A (fi) 1987-07-22
DE3601567A1 (de) 1987-07-23
JPS62169789A (ja) 1987-07-25
HUT45531A (en) 1988-07-28
DK29287D0 (da) 1987-01-20
DD265401A5 (de) 1989-03-01
NO870126D0 (no) 1987-01-13
KR870007176A (ko) 1987-08-17
AU6746387A (en) 1987-07-23

Similar Documents

Publication Publication Date Title
DK451887A (da) Aryloxycarboxylsyrederivater, deres fremstilling og anvendelse
DK569087A (da) Quinolin-derivater, deres fremstilling og anvendelse
DK514586A (da) Quinolinderivater, deres fremstilling og anvendelse
DK374289D0 (da) Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse
DK605489D0 (da) Beta-amino-boronsyre-derivater, deres fremstilling og anvendelse
NO871526D0 (no) Tiolaktam-n-eddiksyrederivater og fremgangsmaate for deres fremstilling.
DK29287A (da) 7-(azabicycloalkyl)-quinoloncarboxylsyre- og -naphthyridonboxylsyrederivater, deres fremstilling og anvendelse
DK595388A (da) Benzopyranderivater, deres fremstilling og anvendelse
DK193088D0 (da) 2-acylpyrrolidin-derivater, deres fremstilling og anvendelse
DK633287D0 (da) Carbamoylimidazo-derivater, deres fremstilling og anvendelse
DK235787A (da) Tripeptidderivater, deres fremstilling og anvendelse
DK278188A (da) Thiazolidin-4-on-derivater, deres fremstilling og anvendelse
DK213387A (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK189488A (da) Imidazothiadiazinderivater, deres fremstilling og anvendelse
DK212687D0 (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK223288D0 (da) Benzensulfornamid-derivater, deres fremstilling og anvendelse
DK610787A (da) Substituerede thienoimidazoltoluidin-derivater, deres fremstilling og anvendelse
DK548586D0 (da) Thienylsulfonylguanidin-derivater, deres fremstilling og anvendelse
DK412188D0 (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK361388D0 (da) Cephemderivater, deres fremstilling og anvendelse
DK613888D0 (da) Acyllabdan-derivater, deres fremstilling og anvendelse
DK668888D0 (da) Labdan-derivater, deres fremstilling og anvendelse
DK668788D0 (da) Labdanderivater, deres fremstilling og anvendelse
DK727388D0 (da) 2-aminotetrahydroisoquinolinderivater, deres fremstilling og anvendelse
NO871576D0 (no) Anthranilsyrederivater og fremgangsmaate for deres fremstilling.

Legal Events

Date Code Title Description
ATS Application withdrawn